array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Mon, 25 Nov 2024 14:01:52 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Iko0MW9GMzJpYjA2ekxWZlRWaVFRRkE9PSIsInZhbHVlIjoiT09BaWtmZ1gvODFXRlptRXdydHNITDc1MVNkZkt0Wm4xOG11a3dIcXN4L1NTZHNyUEQrL0MxNlF0dmQ5U1FQY2NMLzBsbW4rdVpwb3U0dXVlTVk2WUtsVFcrRTVnQ2d1c3ZtZmJidCtycUJob0hQRVZMeTFKbHg1ZTkvZ1kvR2MiLCJtYWMiOiJhOWI1YjdiZTQ3NDRlOTgxMGM3ZGRkYjU4ODAxYzcxNDdhNmNiMzlkZGNjNGNlMTFlNDcxMDRjYWY0M2I0OGM2IiwidGFnIjoiIn0%3D; expires=Thu, 28 Nov 2024 02:01:52 GMT; Max-Age=216000; path=/; secure; samesite=lax"
    1 => "alphaeurekaselectnet_session=eyJpdiI6IlpObmd6YWUyU0pxVkl5UDR1eGhPRkE9PSIsInZhbHVlIjoiWDNGYUp1NnJLWHJ2aW16eGVIcXJEUmd1Qng4cmtabjZ1TkFJN2pIZkNFZkZWV0xuNkd2ZEl2TzlmaDVTb1V2ZUliY2V2ZlJqSTZ4d29Vd2xTNjN2Z0pVQnlOY2pacTU5aXByV3BJSHdWL2VrY2oxdEdtOGcrR0xlNEFqa2xQdEoiLCJtYWMiOiI4NDE2ZWYxZjg4N2JhNzAyZTA2NWExNzFkNDBjZjdlYTJlNmE4MTFlNzE1Njg5OWE1OWJiODYwMWJhODRjY2ZmIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Iko0MW9GMzJpYjA2ekxWZlRWaVFRRkE9PSIsInZhbHVlIjoiT09BaWtmZ1gvODFXRlptRXdydHNITDc1MVNkZkt0Wm4xOG11a3dIcXN4L1NTZHNyUEQrL0MxNlF0dmQ5U1FQY2NMLzBsbW4rdVpwb3U0dXVlTVk2WUtsVFcrRTVnQ2d1c3ZtZmJidCtycUJob0hQRVZMeTFKbHg1ZTkvZ1kvR2MiLCJtYWMiOiJhOWI1YjdiZTQ3NDRlOTgxMGM3ZGRkYjU4ODAxYzcxNDdhNmNiMzlkZGNjNGNlMTFlNDcxMDRjYWY0M2I0OGM2IiwidGFnIjoiIn0%3D; expires=Thu, 28-Nov-2024 02:01:52 GMT; path=/; secure"
    1 => "alphaeurekaselectnet_session=eyJpdiI6IlpObmd6YWUyU0pxVkl5UDR1eGhPRkE9PSIsInZhbHVlIjoiWDNGYUp1NnJLWHJ2aW16eGVIcXJEUmd1Qng4cmtabjZ1TkFJN2pIZkNFZkZWV0xuNkd2ZEl2TzlmaDVTb1V2ZUliY2V2ZlJqSTZ4d29Vd2xTNjN2Z0pVQnlOY2pacTU5aXByV3BJSHdWL2VrY2oxdEdtOGcrR0xlNEFqa2xQdEoiLCJtYWMiOiI4NDE2ZWYxZjg4N2JhNzAyZTA2NWExNzFkNDBjZjdlYTJlNmE4MTFlNzE1Njg5OWE1OWJiODYwMWJhODRjY2ZmIiwidGFnIjoiIn0%3D; path=/; secure; httponly"
  ]
]
Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "lumretuzumab"

HER3 and its Ligand, Heregulin, as Targets for Cancer Therapy

Apply Filters

Content Type
